Regulatory Jobs (@RegProRecruit) header
Regulatory Jobs (@RegProRecruit) profile picture

Regulatory Professionals, part of the Clinical Professionals Group, recruiting for regulatory affairs jobs within the life sciences industry.

UK
Joined August 2013
Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)Photo by Regulatory Jobs (@RegProRecruit)
Trump’s vaccine ‘October surprise’ in doubt as @US_FDA toughens standards bit.ly/3cncMDD #regulatory
.@NICEComms relents and okays Akcea’s rare disease #drug Waylivra for #NHS use bit.ly/2ZYilU5 #regulatory
.@US_FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C) bit.ly/3mAaNAH #regulatory
Senior @US_FDA officials say decision on COVID-19 vaccine will be guided by science bit.ly/33vBSvS #regulatory
ImmuPharma updates on US FDA Special Protocol Assessment submission for Lupuzor's Phase III trial bit.ly/33dT6hi #regulatory
.@Roche, Blueprint Medicines' Gavreto approved in US for RET fusion-positive lung cancer bit.ly/2Zjx7o5 #regulatory
Janssen disappointed with second @NICEComms no for Spravato bit.ly/31VWTAl #regulatory
Improving @US_FDA #COVID19 vaccine authorization and approval process bit.ly/2EO7y7w #regulatory
.@Roche gets @US_FDA approval for 'FoundationOne Liquid CDx' test bit.ly/34IzLHy #regulatory
Industry group says @US_FDA botched #COVID19 convalescent plasma guidance bit.ly/3jlBiHs #regulatory
.@US_FDA hands Cassiopea its first approval, for acne #drug Winlevi bit.ly/3gBRhj0 #regulatory
US regulators have issued a green light for a Phase III clinical trial testing EUSA Pharma's for patients seriously ill with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). bit.ly/3gmqKpT
The US Food and Drug Administration (FDA) has approved ViiV Healthcare's novel attachment inhibitor Rukobia (fostemsavir) expanding treatment options for HIV. bit.ly/2C2AC9w